special software application oncotreat (MeVIS Research GmbH)
90
Structured Review
MeVIS Research GmbH
special software application oncotreat
Special Software Application Oncotreat, supplied by MeVIS Research GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/research+prototype+software/oncology+prototype+software/pm25986465-57-23-27
Average 90 stars, based on 1 article reviews
Special Software Application Oncotreat, supplied by MeVIS Research GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/research+prototype+software/oncology+prototype+software/pm25986465-57-23-27
Average 90 stars, based on 1 article reviews
special software application oncotreat - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for 90Y-Resin Microspheres. Article Snippet: Dose calculations were based on partition model, using exact liver and tumor volumes calculated by Article Title: Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations. Article Snippet: Background: Early diagnosis of lung cancer in a treatable stage is the main purpose of lung cancer screening by computed tomography (CT).. Accurate three-dimensional size and growth measurements are essential to assess the risk of malignancy.. Nodule volumes can be calculated by using semi-automated volumetric software. Article Title: Comparison of manual and semi-automatic measuring techniques in MSCT scans of patients with lymphoma: a multicentre study. Article Snippet: Objectives Multicentre evaluation of the precision of semiautomatic 2D/3D measurements in comparison to manual, linear measurements of lymph nodes regarding their interobserver variability in multi-slice CT (MSCT) of patients with lymphoma.. Methods MSCT data of 63 patients were interpreted before and after chemotherapy by one/tworadiologists in five university hospitals.. In 307 lymph nodes, short (SAD)/long (LAD) axis diameter and WHO area were determined manually and semiautomatically. Article Title: Evaluation of Visualization Using a 50/50 (Contrast Media/Glucose 5% Solution) Technique for Radioembolization as an Alternative to a Standard Sandwich Technique. Article Snippet: Background Radioembolization (RE) with yttrium (Y) resin microspheres generally employs a sandwich technique with separate sequential administration of contrast medium (CM), followed by vehicle (e.g., glucose 5% [G5] solution), then Y resin microspheres (in G5), then G5, and then CM again to avoid contact of CM and microspheres under fluoroscopic guidance.. This study evaluates the visualization quality and safety of a modified sandwich technique with a 50/50-mixture of CM (Imeron 300) and G5 for administration of Y resin microspheres.. Materials and Methods A retrospective analysis of 81 RE procedures in patients with primary or secondary liver tumors was performed. Article Title: Effect of MRI-based semiautomatic size-assessment in cerebral metastases on the RANO-BM classification. Article Snippet: Aim Evaluation of a semiautomatic software algorithm for magnetic resonance imaging (MRI)-based assessment of cerebral metastases in cancer patients.. Material andMethods Brain metastases (n= 131) in 38 patients, assessed by contrast-enhanced MRI, were retrospectively evaluated at two timepoints (baseline, follow-up) by two experienced neuroradiologists in a blinded manner.. The response assessment in neuro-oncology (RANO) criteria for brain metastases (RANO-BM) were applied by means of a software (autoRANO-BM) as well as manually (manRANO-BM) at an interval of 3 weeks. Activity Assay:Article Title: Defining predictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine origin. Article Snippet: Objectives To define predictive parameters of long progressionfree survival (PFS) in patients undergoing radioembolisation of neuroendocrine liver metastases.. Methods The following clinical and magnetic resonance imaging (MRI) parameters of 45 radioembolised patients (median age, 62 years; range, 43–75) were reviewed: age, gender, levels of chromogranin A and neuron-specific enolase (NSE), primary tumour site, Ki-67 proliferation index, hepatic tumour load, number of metastases, signal intensity characteristics, vascularisation, haemorrhagic and necrotic transformation and fluid–fluid levels.. PFS was assessed according to RECIST 1.0. Article Title: Safety of Radioembolization with (90)Yttrium Resin Microspheres Depending on Coiling or No-Coiling of Aberrant/High-Risk Vessels. Article Snippet: .. To avoid an overestimating of the required activity in patients with prior surgical resections, we calculated the exact liver- and tumor-volume using a Software:Article Title: Defining predictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine origin. Article Snippet: Objectives To define predictive parameters of long progressionfree survival (PFS) in patients undergoing radioembolisation of neuroendocrine liver metastases.. Methods The following clinical and magnetic resonance imaging (MRI) parameters of 45 radioembolised patients (median age, 62 years; range, 43–75) were reviewed: age, gender, levels of chromogranin A and neuron-specific enolase (NSE), primary tumour site, Ki-67 proliferation index, hepatic tumour load, number of metastases, signal intensity characteristics, vascularisation, haemorrhagic and necrotic transformation and fluid–fluid levels.. PFS was assessed according to RECIST 1.0. Article Title: Safety of Radioembolization with (90)Yttrium Resin Microspheres Depending on Coiling or No-Coiling of Aberrant/High-Risk Vessels. Article Snippet: .. To avoid an overestimating of the required activity in patients with prior surgical resections, we calculated the exact liver- and tumor-volume using a |